Filtrér søgeresultater ?

Datatyper ?
0
7

Årstal ? (1980 - 2015)
Fra
Til 

Skabt af ?
Antal søgeresultater 7

Forskningsdata
Aflevering 37443
Skabt af: Merete Nordentoft.

-Formålet med studiet er at undersøge langtidseffekten af behandlingsformen OPUS hos patienter med førstegangspsykose.


Forskningsdata
Aflevering 36784
Skabt af: Merete Nordentoft.

Forskningsdata
Aflevering 36785
Skabt af: Merete Nordentoft.

Forskningsdata
Aflevering 37304
Skabt af: Merete Nordentoft.

Studiet formål er at undersøge effekten af et 16-ugers manualiseret program for individuel kognitiv træning integreret i et omfattende psykosocialt program på kognitiv- og dagligdagsfunktionsevne, hos patienter med skizofreni versus et omfattende psykosocialt program alene.


Forskningsdata
Aflevering 36788
Skabt af: Merete Nordentoft.

Forskningsdata
Aflevering 36786
Skabt af: Merete Nordentoft.

Forskningsdata
Aflevering 50528
Skabt af: Psykiatrisk Center København, Merete Nordentoft.

Objective: To compare the effects of five years of specialised early intervention (SEI) treatment for first episode schizophrenia spectrum disorder with the standard two years of SEI plus three years of treatment as usual. Design: Randomised, superiority, parallel group trial with blinded outcome assessment. Randomisation was centralised and computerised with concealed randomisation sequence carried out at an external site. Setting: Participants were recruited from six OPUS teams in Denmark between 2009 and 2012. OPUS teams provide SEI treatment to all patients diagnosed with a schizophrenia spectrum disorder in Denmark. Participants 400 participants (51% women) with a mean age of 25.6 (standard deviation 4.3) were randomised to five years of SEI (experimental intervention; n=197) or to two years of SEI plus three years of treatment as usual (control; n=203). Interventions OPUS treatment consists of three core elements-modified assertive community treatment, family involvement, and social skill training-with a patientcase manager ratio of no more than 12:1. For participants randomised to five years of OPUS treatment, the treatment was largely unchanged. Participants randomised to the control group were mostly referred to community health centres after two years of SEI treatment. Main outcomes:Follow-up assessments were conducted five years after start of OPUS treatment. Primary outcome was negative symptoms measured on the scale for assessment of negative symptoms (avolition-apathy, anhedonia, alogia, and affective blunting). Secondary outcomes were remission of both negative and psychotic symptoms, psychotic symptoms, suicidal ideation, substance abuse, compliance with medical treatment, adherence with treatment, client satisfaction, days in hospital care, and labour market affiliation. Results Levels of negative symptoms did not differ between the intervention group and control group (1.72 v 1.81 points; estimated mean difference-0.10 (95% confidence interval 0.33 to 0.13), P=0.39). Participants receiving five years of OPUS treatment were more likely to remain in contact with specialised mental health services (90.4% v 55.6%, P < 0.001), had higher client satisfaction (estimated mean difference 2.57 points (95% confidence interval 1.36 to 3.79), P< 0.001), and had a stronger working alliance(estimated mean difference 5.56 points (95%confidence interval 2.30 to 8.82), P=0.001) thanthe control group. Conclusions: This trial tests SEI treatment for upto five years for patients with first episodeschizophrenia spectrum disorder; previous trialshave found treatment effects for programmeslasting from one to three years. The prolongedSEI treatment had few effects, which could bedue to the high level of treatment provided tocontrol participants and the late start ofspecialised treatment.